Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Fulgent Genetics, Inc. Director's Dealing 2019

Mar 6, 2019

32553_dirs_2019-03-06_94c8c48d-67da-4eaf-ac30-62fc67e88fd0.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Fulgent Genetics, Inc. (FLGT)
CIK: 0001674930
Period of Report: 2019-03-05

Reporting Person: KIM PAUL (CFO and Treasurer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-03-05 Common Stock S 1165 $4.67 Disposed 400015 Direct

Footnotes

F1: The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on August 10, 2016. The sales were effected in multiple transactions, all at a price of $4.67 per share. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares in each such transaction.